跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
OXALIPLATIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/ML
Approved
THERAPEUTIC
OXALIPLATIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/ML
Pharmachemie B.V.
🇸🇬 Health Sciences Authority
Approval Date
Oct 31, 2011
Approval ID
32f20895a9cde041
Company
Pharmachemie B.V.
Type
Therapeutic
Approval Details
Approval Id
32f20895a9cde041
Drug Name
OXALIPLATIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/ML
Product Name
OXALIPLATIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/ML
Approval Number
SIN14041P
Approval Date
2011-10-31
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XA03
Atc Item Name
oxaliplatin
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
OXALIPLATIN
5MG
OXALIPLATIN
5MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 31, 2011
Approval ID
32f20895a9cde041
Type
Therapeutic
Back to HSA Approvals
OXALIPLATIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/ML - HSA Drug Approval Details
